On June 06, GE Healthcare announced its recent acquisition of Omnimed, a Brazilian manufacturer of mining equipment monitoring vital functions used in surgery centers and Intensive Care Units (ICU). GE did not disclose the acquisition amount, but should result in a gain of 50% in sales of Brazilian division of GE.
Headquartered in Belo Horizonte, the Omnimed is the second acquisition of GE Healthcare in Brazil. In 2012, XPro maker (also from Minas Gerais) of X-ray machines for cardiology, neurology and interventional radiology, was also acquired by GE Healthcare.
According to the company, local purchases are part of the expansion plan in the medical equipment market – led by Dutch Philips in Brazil. There is also the intention to export machines manufactured here to other markets.
From Blind Spots to Better Outcomes: How SNF Data Transparency Strengthens LTSS
What if health plans could identify member decline before an avoidable hospitalization occurs? Real-time clinical visibility into long-stay SNF members uncovers risk earlier and drives better outcomes.
GE Healthcare has been aggressively positioning itself in the Brazilian market. It will soon gain significant market share and dominate the healthcare market in Brazil.
Where Will AI Deployment Benefit Payers the Most?
We are taking a look at how health insurers are using AI, defining success, and managing cybersecurity risks. Give us your opinions by completing our brief, anonymous survey.
Patricia Valenti, MD, MBA, is a senior-level physician executive and healthcare IT subject matter expert with 20 plus years of Program and Project Management experience in scientific/medical and health information technology with a passion for healthcare IT transformation. Currently as ECHO Health IT Networks, Inc. CEO/President, Dr. Valenti is providing leadership to ECHO, advancing its mission and objectives and promoting revenue, profitability and growth of the company. ECHO’s mission derives from providing business and technology vision for organizations wide information services and focusing on cutting-edge technology practices that are patient centric.
Dr. Valenti has extensive experience in Health Data Management and Analysis for Evidence-Based practices, Healthcare Business Intelligence and Data Analytic platforms that provide performance management, health outcomes and patient safety, and financial and operational management solutions. She has represented enterprise’s program’s objectives and interests with the Department of Health and Human Services agencies such as the National Institutes of Health, Centers of Disease Control, Food and Drug Administration, Center for Medicare and Medicaid Services, Walter Reed Army Medical Center, Department of Defense, pharmaceutical companies, universities, health IT and clinical analytic companies.
Furthermore, she has extensive knowledge on Health IT program initiatives and policies by the office of the National Coordinator for Health Information Technology (ONC), the Health Information Technology for Economic and Clinical Health (HITECH) programs, the American Recovery and Reinvestment Act of 2009 (ARRA) and Accountable Care Organizations. National Committee for Quality Assurance, Joint Commission on Accreditation of Healthcare Organizations and URAC standards and guidelines. Dr. Valenti strives to become a major contributor of sustainable health IT transformation programs.
This post appears through the MedCity Influencers program. Anyone can publish their perspective on business and innovation in healthcare on MedCity News through MedCity Influencers. Click here to find out how.